Markets have been shaking through the first half of the year, leaving many investors hitting the pause button as they wait for valuations to stabilize. When is the right time for investors to jump in with confidence that prices have reset and are reasonable marks? 

In this webinar, Aman Verjee, General Partner at Practical Venture Capital, will discuss private and public company valuations, taking a deep dive on pricing in the SaaS sector (“Software as a Service”). 

Join us on July 14 for a webinar on private and public company valuations. Register here.

Here’s a quick preview of the webinar…

It’s time to chat…

Many may not know this, but Ei Ventures started thanks to a fireside chat. Cofounder Jason Hobson and I were in Hawaii. We were talking about the things two friends talk about after a long day… family, friends, work. Life.

One thing we kept coming back to was how many of those that we close to us were in danger. And I’m not talking about physical danger, per se. I’m talking about their mental health.

Life can be tough. It throws us all kinds of curveballs. I know because it’s certainly happened to me. Against the beautiful backdrop of a roaring fire on the beach, we came up with our solution to fight the problem: natural, plant-based medicines that would pay homage to Mother Nature while at the same time actually make a material difference.

Sure, we were a bit ahead of our time. But all pioneers are. In the intervening time, we’ve seen the psychedelics industry go from the fringe to a blowout frenzy… only to come crashing back down.

And this is why we need to chat.

You see, while the market in general may be crazy; and the psychedelics industry might be in a state of flux, I’ve never been more excited. We’re seeing opportunities on front of us today that I thought we’d have to wait years for.

Excellent companies and assets trading for dirt-cheap valuations while at the same time plant medicine is accepted more than ever. This contrast will not last. But now is the perfect time to strike.

That’s also why we recently re-opened our doors to investors for the first time in months. We see so many value-add opportunities in front of us. As always, we will be smart and selective. But I’ve seen market cycles my whole life. And this is the time to get positioned for the next wave.

To talk about all of this – and more – I’ll be co-hosting a fireside chat with my friend and founder of FLAIA, Michael Corcelli. FLAIA is an open access platform to alternative investments – like Regulation A+ and Regulation D. Michael has put on some of the best events in the industry – and I may be a bit biased, but I think this upcoming fireside chat will fit the bill…

The chat will be this coming July 14, 2022 from 11:30 to 12:30 pm. But to attend, you must register. So that we can handle a fair amount of Q&A, we are limiting attendance and we can’t guarantee that a replay will be available, so please make sure to secure your seat by clicking here.

Introduction to Avicanna, an international commercial-stage biopharmaceutical company with a focus on commercial products and pharmaceutical pipeline

Join us as we debut the new and improved FLAIA marketplace. We will review the new features, capabilities and types of products that will be available for review. The marketplace is our new tool that will make it easier for investors to learn about alternative investments in one seamless place, based on your specific interests. Check out our new marketplace - https://flaia.org/marketplace/